Literature DB >> 196666

Calcium and pancreatic beta-cell function. I. Stimulatory effects of pentobarbital on insulin release.

B Hellman.   

Abstract

Islets microdissected from ob/ob-mice were exposed to 3mM pentobarbital in media which were normal or deficient in Ca2+. This treatment resulted in marked decrease of the islet content of cyclic AMP recorded in the presence of the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine. Pentobarbital had a dual effect on insulin release. In addition to being a potent inhibitor of glucose-stimulated insulin release in media containing 2.56 mM Ca2+ it increased the amounts of insulin released in high glucose media deficient in Ca2+. There was a transient stimulation with ordinary concentrations of Ca2+ and 3mM glucose whtn the media also contained 3-isobutyl-1-methylxanthine. The stimulatory effect of pentobarbital persisted after replacing part of the Ca2+ in the beta-cell membrane with lanthanum ions and it could not be mimicked by lowering the oxygen tension of the incubation medium. It is suggested that pentobarbital stimulation of insulin release is the result of a specific action of the drug on the distribution of Ca2+ within the pancreatic beta-cells.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 196666     DOI: 10.1016/0304-4165(77)90297-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  The effect of induced hyperglucagonaemia on the Zucker fatty rat.

Authors:  H A Mahmood; P J Wood; V Marks
Journal:  Diabetologia       Date:  1978-06       Impact factor: 10.122

2.  Environmental risk factors for type 1 diabetes in Rome and province.

Authors:  N Visalli; L Sebastiani; E Adorisio; A Conte; A L De Cicco; R D'Elia; S Manfrini; P Pozzilli
Journal:  Arch Dis Child       Date:  2003-08       Impact factor: 3.791

3.  Barbiturates inhibit ATP-K+ channels and voltage-activated currents in CRI-G1 insulin-secreting cells.

Authors:  R Z Kozlowski; M L Ashford
Journal:  Br J Pharmacol       Date:  1991-08       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.